ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Bilibili Inc (PK)

Bilibili Inc (PK) (BLBLF)

14.35
0.00
(0.00%)
마감 01 2월 6:00AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
14.35
매수가
13.90
매도가
31.45
거래량
-
0.00 일간 변동폭 0.00
11.69 52주 범위 29.85
market_cap
전일 종가
14.35
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
501
발행 주식
409,923,585
배당수익률
-
주가수익률
-1.22
주당순이익(EPS)
-11.76
매출
22.53B
순이익
-4.82B

Bilibili Inc (PK) 정보

섹터
Cmp Processing,data Prep Svc
산업
Cmp Processing,data Prep Svc
웹사이트
본부
Grand Cayman, Cym
설립됨
-
Bilibili Inc (PK) is listed in the Cmp Processing,data Prep Svc sector of the OTC 시장 with ticker BLBLF. The last closing price for Bilibili (PK) was US$14.35. Over the last year, Bilibili (PK) shares have traded in a share price range of US$ 11.69 to US$ 29.85.

Bilibili (PK) currently has 409,923,585 shares in issue. The market capitalisation of Bilibili (PK) is US$5.88 billion. Bilibili (PK) has a price to earnings ratio (PE ratio) of -1.22.

BLBLF 최신 뉴스

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10014.3514.3514.3538414.35CS
4-1.85-11.419753086416.216.214.3595215.82689076CS
12-6.49-31.142034548920.8421.5514.3550117.09298841CS
26-0.35-2.3809523809514.729.8514.3528119.65276353CS
522.0917.047308319712.2629.8511.69339912.58374644CS
156-2.4-14.32835820916.7529.8510.7251212.81205746CS
26014.34914349000.00170.170.001367538.32792873CS

BLBLF - Frequently Asked Questions (FAQ)

What is the current Bilibili (PK) share price?
The current share price of Bilibili (PK) is US$ 14.35
How many Bilibili (PK) shares are in issue?
Bilibili (PK) has 409,923,585 shares in issue
What is the market cap of Bilibili (PK)?
The market capitalisation of Bilibili (PK) is USD 5.88B
What is the 1 year trading range for Bilibili (PK) share price?
Bilibili (PK) has traded in the range of US$ 11.69 to US$ 29.85 during the past year
What is the PE ratio of Bilibili (PK)?
The price to earnings ratio of Bilibili (PK) is -1.22
What is the cash to sales ratio of Bilibili (PK)?
The cash to sales ratio of Bilibili (PK) is 0.26
What is the reporting currency for Bilibili (PK)?
Bilibili (PK) reports financial results in CNY
What is the latest annual turnover for Bilibili (PK)?
The latest annual turnover of Bilibili (PK) is CNY 22.53B
What is the latest annual profit for Bilibili (PK)?
The latest annual profit of Bilibili (PK) is CNY -4.82B
What is the registered address of Bilibili (PK)?
The registered address for Bilibili (PK) is SUITE #4-210, GOVERNORS SQUARE, 23 LIME TREE BAY AVENUE, GRAND CAYMAN, KY1 1209
What is the Bilibili (PK) website address?
The website address for Bilibili (PK) is www.ir.bilibili.com
Which industry sector does Bilibili (PK) operate in?
Bilibili (PK) operates in the CMP PROCESSING,DATA PREP SVC sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
NXGBNxGen Brands Inc (CE)
US$ 0.003
(299,900.00%)
180.55k
DOCKFBeyond Med Technologies Inc (PK)
US$ 0.055
(54,900.00%)
3.05k
SDCCQSmileDirectClub Inc (CE)
US$ 0.0004
(39,900.00%)
52.05k
LTFDLittlefield Corporation (CE)
US$ 0.1525
(38,025.00%)
240
SGMDSugarmade Inc (CE)
US$ 0.0003
(29,900.00%)
5.94k
RTNBroot9B Holdings Inc (CE)
US$ 0.000001
(-99.97%)
666
THMOThermoGenesis Holdings Inc (CE)
US$ 0.000001
(-99.86%)
250
DOMWFPrime Drink Group Corporation (PK)
US$ 0.0012
(-99.08%)
311.03k
TTCMTautachrome Inc (CE)
US$ 0.000001
(-99.00%)
125.07k
MITJFMint Corporation (CE)
US$ 0.0001
(-99.00%)
12k
HCMCHealthier Choices Management Corporation (PK)
US$ 0.000001
(0.00%)
316.07M
HMBLHUMBL Inc (PK)
US$ 0.0007
(0.00%)
218.85M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(-25.00%)
210.68M
RONNRonn Motor Group Inc (PK)
US$ 0.0003
(0.00%)
171.31M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00275
(-1.79%)
134.31M
Kam8 Kam8 15 분 전
LP just doesn't accept Settlement and go discovery🤞😆🤞, I don't think MMs want discovery so they might accept big money for settlement. 😆😆
NWBO
manibiotech manibiotech 15 분 전
Agree
Usual few will pump this anyway 
NWBO
manibiotech manibiotech 16 분 전
lol 
The ceiling has already been put at 40M shares
So dream on
NWBO
Deportes Deportes 18 분 전
Gfy is that better?
ENZC
Hicham007 Hicham007 18 분 전
Painful but nothing new...

I have averaged down my portfolio to 6.6$ down from 9.8 and I have now 140k shares and i am ready to increase it to 200k if the SP continues on  dropping.  By now Iova is my only stock market investment so we can say all In...

I am ready finan
IOVA
jammy32 jammy32 19 분 전
As soon as Trump the genius mentioned Tariffs on pharmaceuticals, this puppy got sick and dropped seven cents. Not good. Shouldn’t Nasrat tell us what this means for Elite. Are we subject to the tariffs where is the API from. Is this a good thing or bad thing. Does nasrat know. Does he
API
rosemountbomber rosemountbomber 19 분 전
Sleven am I understanding correctly that the Generics get their API from China and Amarin doesn't?
API
BlazingStocks BlazingStocks 20 분 전
$ILLR Triller CEO Sean Kim joins Yahoo Finance to discuss the fight for TikTok's market share and the outlook for the creator economy:https://x.com/YahooFinance/status/1885453406485033258?t=ldZluPpc4DCzgBoH3GagOA&s=19
ILLR
barnstormer barnstormer 20 분 전
OK Zadie, the judge only allowed a lousy 40 million shares. Still, consider the following (quick back of the envelope math)

40,000,000 shares / (2752(avg daily volume) x 252 (avg yearly trading days) = 700,104 avg yearly shares traded
40,000,000 shares / 700,104 = 57.14 years
NWBO
BlazingStocks BlazingStocks 21 분 전
Thank you for sharing this! 
ILLR
VMLG17 VMLG17 21 분 전
And they’d be stupid if they didn’t settle. If a jury learns that the MMs have continued spoofing after the lawsuit was filed, then damages could be more than any settlement amount, not to mention criminal charges later.
NWBO
Macod Macod 21 분 전
CHANGE in outstanding shares. First change in over a year. Should be more shares reflected with next update. Those lucky enough to buy privates be on the lookout for your certs

O/S 526,142,269
Restricted 297,633,160
Unrestricted 228,509,109

Increase of 7,6
MRGE
mascale mascale 21 분 전
Hiru Prepared: Likely for new JORC, 2025, Canadian standard less likely needed. ERM is noted in Hiru basis reporting. "Resource reporting and compliance: we prepare mineral resource reports in accordance with international reporting standards such as NI 43-101, JORC, and CIM. Our experts ensure t
HIRU
stealofadeal stealofadeal 22 분 전
$ BLTHD The way this is looking with not much on the offer we are going much higher. We are sitting way under the radar. I saw 12.00 the third market maker down on the ask.
BLTHD
nowwhat2 nowwhat2 22 분 전
scoop um up right at black swan.
XRPUSD
loophole lawyer loophole lawyer 23 분 전
The 3 most important letters for GTCH…..P,C,T……Checkmate
GTCH
Preciouslife1 Preciouslife1 23 분 전
https://www.mlb.com/news/mets-counting-on-trade-deadline-additions
jxyzobrien jxyzobrien 24 분 전
hope you are well
sounds like your company is doing great
say hi when you can
flipper44 flipper44 24 분 전
The court’s R&R did conclude and preserve NWBO illegal spoofing claims alleged to have been committed by defendants.
NWBO
x993231 x993231 26 분 전
He does like to make a mountain out of a mole hill, but that is what he gets paid to do.  I have him and many of his alternate ID's on ignore.  He is good at asking, why, why, why.  

X. Yves is good at doing his thing.  Funny remember when Lebby said if I don't perform by the end of t
LWLG
havnagoodtime havnagoodtime 26 분 전
So, what is the short interest and the FTD report on DPLS? Thanks in advance.
DPLS
MartinLutherKing MartinLutherKing 27 분 전
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ
gladeshawk gladeshawk 27 분 전
AIRI>>>NEWS. Not a penny play but worth a look. HAWK

https://finance.yahoo.com/news/air-industries-group-closes-fiscal-120000021.html
AIRI
MartinLutherKing MartinLutherKing 27 분 전
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ
vein vein 27 분 전
Hey Bubb, I see the cfo received shares , but I don't see the CEO s4??? 
CKPT